BioCentury
ARTICLE | Financial News

GTx planning follow-on

October 27, 2010 12:02 AM UTC

GTx Inc. (NASDAQ:GTXI) said late Tuesday that it is planning a follow-on underwritten by Lazard. Further details were not disclosed. GTx's toremifene citrate, a non-steroidal selective estrogen recept...